Abstract

Abstract The B7 family consists of structurally related, cell-surface proteins that regulate immune responses by delivering costimulatory or coinhibitory signals through their ligands. Eight family members have been identified to date including CD80 (B7-1), CD86 (B7-2), CD274 (programmed cell death-1 ligand [PD-L1]), CD273 (programmed cell death-2 ligand [PD-L2]), CD275 (inducible costimulator ligand [ICOS-L]), CD276 (B7-H3), B7-H4, and B7-H6. B7 ligands are expressed on both lymphoid and nonlymphoid tissues. The importance of the B7 family in regulating immune responses is clear from their demonstrated role in the development of immunodeficiency and autoimmune diseases. Manipulation of the signals delivered by B7 ligands shows great potential in the treatment of cancers including leukemias and lymphomas and in regulating allogeneic T-cell responses after stem cell transplantation.

Keywords

Hematologic NeoplasmsHematologic malignancyMedicineMalignancyImmunologyInternal medicineCancer

Affiliated Institutions

Related Publications

Publication Info

Year
2012
Type
review
Volume
121
Issue
5
Pages
734-744
Citations
181
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

181
OpenAlex

Cite This

Paul Greaves, John G. Gribben (2012). The role of B7 family molecules in hematologic malignancy. Blood , 121 (5) , 734-744. https://doi.org/10.1182/blood-2012-10-385591

Identifiers

DOI
10.1182/blood-2012-10-385591